» Articles » PMID: 23751942

Pachychoroid Pigment Epitheliopathy

Overview
Journal Retina
Date 2013 Jun 12
PMID 23751942
Citations 197
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To report nine cases of pachychoroid pigment epitheliopathy.

Methods: An observational case series of nine patients who underwent comprehensive ophthalmic examination, fundus photography, fundus autofluorescence, spectral-domain optical coherence tomography, and enhanced depth imaging optical coherence tomography.

Results: Eighteen eyes of 9 patients, aged 27 years to 89 years, were diagnosed with pachychoroid pigment epitheliopathy based on the characteristic funduscopic appearance of reduced fundus tessellation with overlying retinal pigment epithelial changes in one or both eyes, fundus autofluorescence abnormalities, and increased subfoveal choroidal thickness confirmed by enhanced depth imaging optical coherence tomography (mean, 460.2 μm). The five older patients had been previously diagnosed with age-related macular degeneration, while the four younger subjects were referred for possible inflammatory chorioretinitis, pattern dystrophy, or nonspecific drusen. No subjects had a history of or subsequently developed subretinal fluid.

Conclusion: Pachychoroid pigment epitheliopathy falls within a spectrum of diseases associated with choroidal thickening that includes central serous chorioretinopathy and polypoidal choroidal vasculopathy, and it should be suspected in eyes with a characteristic fundus appearance related to choroidal thickening and associated retinal pigment epithelial abnormalities but no history of subretinal fluid. Enhanced depth imaging optical coherence tomography confirming an abnormally thick choroid and characteristic retinal pigment epithelial changes on fundus autofluorescence support the diagnosis. Because these patients are frequently misdiagnosed, the recognition of pachychoroid pigment epitheliopathy may avoid unnecessary diagnostic testing and interventions.

Citing Articles

Imaging in Pachychoroid Disease.

Demirel S, Yan A, Valsecchi N, Chhablani J Turk J Ophthalmol. 2025; 55(1):36-48.

PMID: 39905979 PMC: 11866993. DOI: 10.4274/tjo.galenos.2024.40388.


Peripapillary pachychoroid syndrome, a different pathway in venous remodelling of the choroidal vasculature.

Donvito G, Primavera V Am J Ophthalmol Case Rep. 2025; 37:102248.

PMID: 39895873 PMC: 11786914. DOI: 10.1016/j.ajoc.2025.102248.


Choroidal Remodeling After Subthreshold Micropulse Laser in Chronic Central Serous Chorioretinopathy: Short-Term Outcomes.

Viggiano P, Scotti G, Termite A, Savastano A, Boscia G, Clemente A J Clin Med. 2025; 14(2).

PMID: 39860311 PMC: 11765888. DOI: 10.3390/jcm14020306.


Quantitative analysis of choroidal vascular structures and anatomical changes in pachychoroid spectrum diseases using ultra-widefield SS-OCTA.

Xiao B, Song Y, Yan M, Ye Y, Huang Z Sci Rep. 2025; 15(1):344.

PMID: 39747120 PMC: 11695674. DOI: 10.1038/s41598-024-82745-5.


Pachychoroid as a Risk Factor for Exudative Retinal Detachment After Panretinal Photocoagulation: A Report of Two Cases.

Videkar R, Al Hasid H, Kamal M, Amula G, Lamba M Cureus. 2024; 16(11):e73228.

PMID: 39650957 PMC: 11624955. DOI: 10.7759/cureus.73228.